Approvals/TGA/VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle

Approved

STANDARD

VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 63eecc2f39b3e900
Product Name: VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle
Artg Id: 220176
Artg Name: VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2014-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

63eecc2f39b3e900

Type

Standard